ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,056,000 | +116.3% | 368,135 | +13.8% | 0.03% | +112.5% |
| Q1 2019 | $7,885,000 | +71.4% | 323,419 | +0.2% | 0.02% | +60.0% |
| Q4 2018 | $4,600,000 | -3.0% | 322,822 | +3.5% | 0.01% | +11.1% |
| Q3 2018 | $4,741,000 | -9.5% | 311,935 | -0.0% | 0.01% | -18.2% |
| Q2 2018 | $5,236,000 | +5.8% | 312,045 | +2.9% | 0.01% | 0.0% |
| Q1 2018 | $4,948,000 | +23.2% | 303,200 | -3.4% | 0.01% | +37.5% |
| Q4 2017 | $4,017,000 | +18.2% | 313,829 | +13.6% | 0.01% | 0.0% |
| Q3 2017 | $3,398,000 | +32.8% | 276,259 | -9.6% | 0.01% | +60.0% |
| Q2 2017 | $2,559,000 | -13.2% | 305,740 | -7.2% | 0.01% | -16.7% |
| Q1 2017 | $2,947,000 | -2.8% | 329,601 | -4.5% | 0.01% | 0.0% |
| Q4 2016 | $3,033,000 | +46.9% | 345,101 | +12.8% | 0.01% | +50.0% |
| Q3 2016 | $2,065,000 | +91.6% | 305,901 | +1.0% | 0.00% | +100.0% |
| Q2 2016 | $1,078,000 | +22.4% | 302,901 | +1.4% | 0.00% | 0.0% |
| Q1 2016 | $881,000 | -20.1% | 298,767 | +14.3% | 0.00% | -33.3% |
| Q4 2015 | $1,103,000 | -5.8% | 261,431 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $1,171,000 | -37.0% | 256,731 | -0.3% | 0.00% | -25.0% |
| Q2 2015 | $1,858,000 | -1.5% | 257,631 | +0.6% | 0.00% | 0.0% |
| Q1 2015 | $1,887,000 | +70.8% | 255,996 | +9.6% | 0.00% | +33.3% |
| Q4 2014 | $1,105,000 | +33.1% | 233,596 | +0.4% | 0.00% | +50.0% |
| Q3 2014 | $830,000 | -20.9% | 232,602 | +1.1% | 0.00% | -33.3% |
| Q2 2014 | $1,049,000 | -0.4% | 229,982 | +2.7% | 0.00% | 0.0% |
| Q1 2014 | $1,053,000 | -6.1% | 223,982 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,122,000 | -14.2% | 223,982 | +6.6% | 0.00% | -25.0% |
| Q3 2013 | $1,307,000 | +41.5% | 210,082 | +3.2% | 0.00% | +33.3% |
| Q2 2013 | $924,000 | -6.8% | 203,491 | +1.0% | 0.00% | 0.0% |
| Q1 2013 | $991,000 | – | 201,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |